Literature DB >> 24903676

The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus.

Carlos D Gómez1, Rudolf M Buijs, María Sitges.   

Abstract

In the present study, the effects of the two classical anti-epileptic drugs, carbamazepine and valproic acid, and the non-classical anti-seizure drug vinpocetine were investigated on the expression of the pro-inflammatory cytokines IL-1β and TNF-α in the hippocampus of rats by PCR or western blot after the administration of one or seven doses. Next, the effects of the anti-seizure drugs were investigated on the rise in cytokine expression induced by lipopolysaccharides (LPS) inoculation in vivo. To validate our methods, the changes induced by the pro-convulsive agents 4-aminopyridine, pentylenetetrazole and pilocarpine were also tested. Finally, the effect of the anti-seizure drugs on seizures and on the concomitant rise in pro-inflammatory cytokine expression induced by 4-aminopyridine was explored. Results show that vinpocetine and carbamazepine reduced the expression of IL-1β and TNF-α from basal conditions, and the increase in both pro-inflammatory cytokines induced by LPS. In contrast, valproic acid failed to reduce both the expression of the cytokines from basal conditions and the rise in IL-1β and TNF-α expression induced by LPS. Tonic-clonic seizures induced either by 4-aminopyridine, pentylenetetrazole or pilocarpine increased the expression of IL-1β and TNF-α markedly. 4-aminopyridine-induced changes were reduced by all the tested anti-seizure drugs, although valproic acid was less effective. We conclude that the anti-seizure drugs, vinpocetine and carbamazepine, whose mechanisms of action involve a decrease in ion channels permeability, also reduce cerebral inflammation. The mechanism of action of anti-seizure drugs like vinpocetine and carbamazepine involves a decrease in Na(+) channels permeability. We here propose that this mechanism of action also involves a decrease in cerebral inflammation.
© 2014 International Society for Neurochemistry.

Entities:  

Keywords:  4-aminopyridine; Anti-epileptic drugs; brain inflammation; epilepsy; lipopolysaccharides; sodium channels

Mesh:

Substances:

Year:  2014        PMID: 24903676     DOI: 10.1111/jnc.12784

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

Review 2.  Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease.

Authors:  Antonella Cardinale; Francesca R Fusco
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

3.  Clinical plasma concentration of vinpocetine does not affect osteogenic differentiation of mesenchymal stem cells.

Authors:  Esma Yıldırım; Gulay Sezer
Journal:  Pharmacol Rep       Date:  2020-08-31       Impact factor: 3.024

4.  Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.

Authors:  Maria Sitges; Blanca Irene Aldana; Ronald Charles Reed
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

5.  Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus.

Authors:  Xiang-Fei Meng; Lan Tan; Meng-Shan Tan; Teng Jiang; Chen-Chen Tan; Meng-Meng Li; Hui-Fu Wang; Jin-Tai Yu
Journal:  J Neuroinflammation       Date:  2014-12-17       Impact factor: 8.322

6.  Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.

Authors:  Kenji W Ruiz-Miyazawa; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Gabriela F Pavão-de-Souza; Rubia Casagrande; Waldiceu A Verri
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

7.  Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.

Authors:  Tingting Fu; Qingxia Kong; Huaqiang Sheng; Lingyun Gao
Journal:  Neural Plast       Date:  2016-01-27       Impact factor: 3.599

8.  Inflammatory cytokine-induced changes in neural network activity measured by waveform analysis of high-content calcium imaging in murine cortical neurons.

Authors:  Benjamin D S Clarkson; Robert J Kahoud; Christina B McCarthy; Charles L Howe
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

9.  The Effect of Vinpocetine on Human Cytochrome P450 Isoenzymes by Using a Cocktail Method.

Authors:  Lingti Kong; Chunli Song; Linhu Ye; Daohua Guo; Meiling Yu; Rong Xing
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-24       Impact factor: 2.629

10.  Promoter-Specific Hypomethylation Correlates with IL-1β Overexpression in Tuberous Sclerosis Complex (TSC).

Authors:  A Fuso; A M Iyer; J van Scheppingen; M Maccarrone; T Scholl; J A Hainfellner; M Feucht; F E Jansen; W G Spliet; P Krsek; J Zamecnik; A Mühlebner; E Aronica
Journal:  J Mol Neurosci       Date:  2016-04-28       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.